REPORT DOCUMENTATION PAGEForm Rublic reportirpg burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget, Paperwork Reduction Project (0704-0188), Washington, DC 20503
AGENCY USE ONLY (Leave blank)2. REPORT DATE
June 2001
REPORT TYPE AND DATES COVEREDAnnual (1 Jun 00 -31 May 01)
TITLE AND SUBTITLEMiniaturized DNA Biosensor for Decentralized Breast-Cancer Screening
AUTHOR(S)Joseph Wang, Ph.D.
FUNDING NUMBERSDAMD17-00-1-0366
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES)New Mexico State University Las Cruces, New Mexico 88003 E-Mail: joewang@nmsu.edu The use of DNA testing as an important component of breast cancer diagnosis has been increasing rapidly during the 1990s. The goal of this research is to develop, optimize, and test a miniaturized sensing system for the rapid and reliable genetic screening detection of breast-cancer. In accordance to our original goal our studies have focused on various fundamental and practical aspects of electrical detection of DNA segments specific to the breast-cancer gene BRCA1. We have made a substantial progress, and introduced new electrical strategies and routes for improving the reliability of devices for genetic screening of breast-cancer. In particular, we have successfully combined the unique amplification features of new metal nanoparticles or enzyme tags, with an effective magnetic separation (isolations of the duplex, and a powerful electrical detection for achieving the task of selective and sensitive breast-cancer ■ screening. Additional developmental work, particularly further improvements in the sensitivity and sample preparation, is in progress towards the realization of wide-scale decentralized screening for breast cancer. Electrochemical devices have received considerable attention in the development of sequence-specific DNA hybridization biosensors. Such devices rely on the conversion of the DNA base-pair recognition event into a useful electrical signal. The high sensitivity of such devices, coupled to their compatibility with modern microfabrication technologies, portability, low cost (disposability), minimal power requirements, and independence of sample turbidity or optical pathway, make them excellent candidates for centralized and decentralized DNA diagnostics. Direct electrical reading of DNA hybridization thus offers great promise for developing simple, rapid, and user-friendly DNA sensing devices (in a manner analogous to miniaturized blood-glucose meters). Recent efforts have led to a host of new s...